“…For example, the BRIEF has been used to assess the effects of medications on executive functions in the everyday life of individuals with attention-deficit hyperactivity disorder (ADHD; Biederman et al, 2011;Dupaul et al, 2012;Findling, Ginsberg, Jain, & Gao, 2009;Maziade et al, 2009;Turgay et al, 2010;Yang et al, 2011), Tourette syndrome (Cummings, Singer, Krieger, Miller, & Mahone, 2002), traumatic brain injury (TBI; Beers, Skold, Dixon, & Adelson, 2005), hepatitis C virus (Rodrigue et al, 2011), major depressive disorder (Roth et al, 2012), and hypertension (Lande et al, 2010). It has also been employed to examine outcomes following interventions such as liver transplantation (Sorensen et al, 2011), chemotherapy in breast cancer (Kesler, Kent, & O'Hara, 2011;McDonald, Conroy, Smith, West, & Saykin, 2013), corticosteroid treatment in children with inflammatory bowel disease (Mrakotsky et al, 2013), and family-based intervention in TBI (Wade, Wolfe, Brown, & Pestian, 2005;Wade, Wolfe, & Pestian, 2004). The BRIEF has also been used to evaluation the outcome of cognitive remediation approaches in ADHD (Beck, Hanson, Puffenberger, Benninger, & Benninger, 2010;Hahn-Markowitz, Manor, & Maeir, 2011) and TBI (Toglia, Johnston, Goverover, & Dain, 2010).…”